As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more and more cases linking them ...

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...

A 59-year-old man suffering from Guillain-Barre Syndrome (GBS) has died in a hospital here, taking the death toll due to the ...

Traumatic optic neuropathy is visual loss caused by trauma to the optic nerve. Injuries, classified as direct or indirect, are also characterized by location. Intracanalicular optic nerve injury ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a ...

Vincristine is a commonly used chemotherapy drug in the treatment of pediatric acute lymphoblastic leukemia ... as vincristine-induced peripheral neuropathy (VIPN), which can significantly ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...